Skip to main content

Advertisement

Table 3 Differences (mean ± SD) in BMD at the total hip and heel in nitrate users and nonusers. Unadjusted and after adjusting for estrogen use and baseline differences (26).

From: The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]

  Percent difference in BMD (95% CI)
  Daily – nonusers Intermittent – nonusers
Hip BMD   
Unadjusted 0 (-2.7 to 1.4) 0 (-4.1 to 4.1)
Adjusted* 1.3 (0.14 to 4.1) 2.6 (0.4 to 6.8)
Heel BMD   
Unadjusted -2.6 (-5.3 to 0) 0 (-5.3 to 7.9)
Adjusted* 0 (-2.6 to 2.6) 5.3 (2.6 to 11)
  1. *Adjusted for estrogen use and baseline differences (37), which are current alcohol intake, walks for exercise, physical activity, self-reported health status, falls in the past 12 months, thiazide and nonthiazide diuretic use, inability to rise from a chair independently and frail on physical examination.